| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 31,435 | 35,449 | 28,761 | 29,224 | | Cost of Revenue | 19,901 | 21,836 | 17,154 | 18,202 | | | Gross Profit | 11,534 | 13,613 | 11,607 | 11,023 | | | Operating Expenses | | Research Development | 3,028 | 2,742 | 1,981 | 1,841 | | Selling General and Administrative | 3,763 | 6,943 | 7,492 | 6,675 | | Non Recurring |
-
| 38 | (38) | (27) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,743 | 3,891 | 2,173 | 2,534 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23 | (6) | 78 | 92 | | Earnings Before Interest And Taxes | 4,766 | 3,884 | 2,251 | 2,625 | | Interest Expense | 70 | 63 | 75 | 117 | | Income Before Tax | 4,696 | 3,821 | 2,175 | 2,508 | | Income Tax Expense | 1,828 | 1,394 | 851 | 925 | | Minority Interest | (11) | (7) | (9) | (10) | | | | Net Income From Continuing Ops | 2,857 | 2,421 | 1,314 | 1,573 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,857 | 2,421 | 1,314 | 1,573 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,857 | $2,421 | $1,314 | $1,573 |
|
0.51% Nasdaq 
Income Statement
